VNRX: סך הכנסות החברה VolitionRx

The sales history of VolitionRx Limited (VNRX) demonstrates how the implementation of annual oncology screenings ensures a steady client inflow and high margins. The business is currently scaling IT solutions for liquid biopsy, combining the veterinary segment with clinical tests. The value of 0.00 represents the current level of the indicator, confirming the status of a high-tech brand whose epigenetic blood analysis precision commands absolute trust from laboratories.

This metric aggregates daily cash inflows, directly reflecting revenue dynamics through financial reporting data. In an inflationary environment, the nominal stability of this metric signals a real decline in the business's purchasing power. For the scientific model of VolitionRx Limited (VNRX), which relies on a costly staff of biologists, this flow is critical for maintaining the academic pace of development. An analysis of corporate sales allows for an assessment of the funding stability for epigenetic research.